UMass Chan Medical School
UMass Chan Medical School
Worcester, Massachusetts, United States20 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Low-dose Imaging TechniquE in Breast MRI | Breast MRI | Not yet recruiting | Not applicable | 2026-10-07 | NCT07864519 | |
| Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorder | Recruiting | Phase 3 | 2026-10-06 | NCT07428538 | |
| The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-30 | NCT05836987 | |
| SAINT in Postpartum Depression (PPD) | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, depressive disorder, mood disorder, postpartum depression, pregnancy disorder, psychiatric disorder, puerperal disorder | Recruiting | Not applicable | 2026-09-28 | NCT07210255 | |
| Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stroke, Acute, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-14 | NCT05065216 | |
| A Study of Obexelimab in Patients With Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Active, not recruiting | Phase 2 | 2026-08-18 | NCT06559163 | |
| Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-08-07 | NCT07637994 | |
| A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Tourette syndrome, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, psychiatric disorder, tic disorder | Active, not recruiting | Phase 3 | 2026-07-22 | NCT06021522 | |
| Okami Medical ALPHA Registry | Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pulmonary Arteriovenous Fistulas | Enrolling by invitation | Not stated | 2026-07-21 | NCT07525518 | |
| A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, metabolic dysfunction-associated steatohepatitis | Active, not recruiting | Phase 3 | 2026-07-08 | NCT05500222 | |
| Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 4 | 2026-05-22 | NCT06174116 | |
| PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-04-16 | NCT05313165 | |
| Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation | Arrhythmias, Cardiac, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, atrial flutter, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, hematologic disorder, hemorrhagic disease, nervous system disorder, stroke disorder, vascular disorder, vascular hemostatic disease | Enrolling by invitation | Not applicable | 2026-04-13 | NCT05997914 | |
| PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | ASCVD; Type2Diabetes | Recruiting | Phase 4 | 2026-04-13 | NCT05390892 | |
| Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Enrolling by invitation | Not applicable | 2026-03-30 | NCT05236556 | |
| Percutaneous Closure Versus Figure-of-eight Suture for Hemostasis in Leadless Pacemaker Implantation. | Leadless Pacemaker; Pacemaker Implantation; Vascular Closure | Enrolling by invitation | Not applicable | 2026-03-27 | NCT06837870 | |
| A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, acute myeloid leukemia, acute myeloid leukemia with mutated NPM1, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myeloid leukemia, myeloid sarcoma, neoplasm, sarcoma | Recruiting | Phase 1 | 2026-03-13 | NCT05735184 | |
| nCCR for Chemotherapy Related Cognitive Impairment Randomized Study | Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Cognitive Dysfunction, Drug-Related Side Effects and Adverse Reactions, cognitive disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-01-08 | NCT05283629 | |
| Association of Digital Aid Use With Infant Sleep and Maternal Mental Health | Infant Development; Maternal Behavior | Active, not recruiting | Not stated | 2025-11-14 | NCT06593236 | |
| Long-Term Follow-Up of Subjects Treated With AXO-AAV-GM2 for Tay-Sachs or Sandhoff Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, GM2 gangliosidosis, Gangliosidoses, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, Sandhoff disease, Tay-Sachs disease, brain disorder, central nervous system disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis | Active, not recruiting | Not stated | 2025-10-16 | NCT06614569 |